In future, it is likely that the clinical indications for GLP- 1RAs will expand, with pharmaceutical companies running various drug trials to substantiate a wider array of use cases, such as the reduction of cardiovascular risk and the treatment of chronic kidney disease
By contrast, 36% of Zepbound users (15mg) lost more than 25% of their body weight in 72 weeks, according to Eli Lilly
(More information) It is not yet clear whether supplementation with B vitamins, antioxidants, or omega-3 fatty acids protects against age-related cognitive decline
PMID: 34170647 | doi:10.1056/NEJMoa2107519 Del Prato S et al
Your clinician will give exact instructions for timing and missed doses
Safety and appropriate patient selection always come first